Cosmos Health (COSM) announced its entry into the U.S. market and the launch of U.S.-based manufacturing through a strategic ...

DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded in 1993.

DolCas Biotech, a developer and manufacturer of clinically studied nutraceutical ingredients, will produce Cosmos Health’s products at its U.S. facilities.

About DolCas Biotech LLC DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded in ...

DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded in 1993. Its portfolio ...

About DolCas Biotech LLC DolCas Biotech LLC is a U.S.-based developer and marketer of branded, science-backed nutraceutical ingredients, founded in 2007 as an extension of Orcas Naturals founded ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other industries as biotechnology has delivered only subpar investor returns.

Five years later, Noah is a healthy third grader who will turn 9 in July, and the biotech business his dad launched, Luminoah, is also thriving. Piper, who lives in Charlottesville with his family, ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.You can reach Elaine on Signal at elaineywchen.70.

Biotech firms are gaining major traction in 2025 due to the global pandemic. Take a look at some of the key features of biotech stocks before investing.

The R&D tax credit isn’t the only area in which changes to tax policy could boost the biotech industry in Connecticut. Currently, the state’s R&D tax credit is available only to C Corporations.